Skip to main content
. 2019 Nov 18;11:9749–9759. doi: 10.2147/CMAR.S213769

Figure 2.

Figure 2

MBD2 reduces Ki-67 expression via inhibition of Sp1 binding to Ki-67 promoter. (A) MeCP2, MBD2 and MBD3 proteins binding to the methylated Ki-67 promoter were analyzed through ChIP assays in MKN45 cells. (B) The binding ability of MBD2 to methylated Ki-67 promoter was determined by ChIP assays in MKN45 and HK-2 cells. (C) qRT-PCR results of Ki-67 mRNA level after the overexpression and knock-down of MBD2 gene in HK-2 cells. (D) ChIP assays analyzed the effects of overexpression and knock-down of MBD2 on Sp1 binding to Ki-67 promoter. (E) Correlation statistic between Sp1 and Ki-67 (MKI67) in gastric cancer samples was performed using GEPIA web tool. **P<0.01; ***P<0.001.

Abbreviations: MBD, methylated CpG-binding protein; TPM, transcripts per million; Ki-67, MKI67; siMBD2, small interfering RNA of MBD2; siCtrl, small interfering RNA of negative control.